Carcinoma-associated fibroblast–like differentiation of human mesenchymal stem cells PJ Mishra, PJ Mishra, R Humeniuk, DJ Medina, G Alexe, JP Mesirov, ... Cancer research 68 (11), 4331-4339, 2008 | 1079 | 2008 |
A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance PJ Mishra, R Humeniuk, PJ Mishra, GSA Longo-Sorbello, D Banerjee, ... Proceedings of the National Academy of Sciences 104 (33), 13513-13518, 2007 | 542 | 2007 |
MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine PJ Mishra, JR Bertino Pharmacogenomics 10 (3), 399-416, 2009 | 336 | 2009 |
Microwave sintering of W–Ni–Fe alloy A Upadhyaya, SK Tiwari, P Mishra Scripta Materialia 56 (1), 5-8, 2007 | 286 | 2007 |
MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics PJ Mishra, PJ Mishra, D Banerjee, JR Bertino Cell cycle 7 (7), 853-858, 2008 | 264 | 2008 |
Mesenchymal stem cells: flip side of the coin PJ Mishra, PJ Mishra, JW Glod, D Banerjee Cancer Research 69 (4), 1255-1258, 2009 | 249 | 2009 |
The therapeutic potential of mesenchymal stem cells: Cell-& tissue-based therapy SC Picinich, PJ Mishra, PJ Mishra, J Glod, D Banerjee Expert opinion on biological therapy 7 (7), 965-973, 2007 | 193 | 2007 |
Modeling of microwave heating of particulate metals P Mishra, A Upadhyaya, G Sethi Metallurgical and Materials Transactions B 37, 839-845, 2006 | 170 | 2006 |
MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism PJ Mishra, B Song, PJ Mishra, Y Wang, R Humeniuk, D Banerjee, ... PloS one 4 (12), e8445, 2009 | 150 | 2009 |
MicroRNA reexpression as differentiation therapy in cancer PJ Mishra, G Merlino The Journal of clinical investigation 119 (8), 2119-2123, 2009 | 132 | 2009 |
MicroRNAs as promising biomarkers in cancer diagnostics PJ Mishra Biomarker research 2, 1-4, 2014 | 121 | 2014 |
Probing the role of a mobile loop in substrate binding and enzyme activity of human salivary amylase N Ramasubbu, C Ragunath, PJ Mishra Journal of molecular biology 325 (5), 1061-1076, 2003 | 111 | 2003 |
Human salivary α‐amylase Trp58 situated at subsite− 2 is critical for enzyme activity N Ramasubbu, C Ragunath, PJ Mishra, LM Thomas, G Gyémánt, ... European Journal of Biochemistry 271 (12), 2517-2529, 2004 | 100 | 2004 |
Pharmacogenomics of microRNA: a miRSNP towards individualized therapy JR Bertino, D Banerjee, PJ Mishra Pharmacogenomics 8 (12), 1625-1627, 2007 | 90 | 2007 |
Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance R Humeniuk, LG Menon, PJ Mishra, R Gorlick, R Sowers, W Rode, ... Molecular cancer therapeutics 8 (5), 1037-1044, 2009 | 88* | 2009 |
Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation PJ Mishra, L Ha, J Rieker, EV Sviderskaya, DC Bennett, MD Oberst, ... Oncogene 29 (16), 2449-2456, 2010 | 83 | 2010 |
Neratinib, a novel HER2-targeted tyrosine kinase inhibitor SR Tiwari, P Mishra, J Abraham Clinical breast cancer 16 (5), 344-348, 2016 | 79 | 2016 |
Cell-free derivatives from mesenchymal stem cells are effective in wound therapy PJ Mishra, PJ Mishra, D Banerjee World Journal of Stem Cells 4 (5), 35, 2012 | 70 | 2012 |
MicroRNA regulation of CYP 1A2, CYP3A4 and CYP2E1 expression in acetaminophen toxicity P Gill, S Bhattacharyya, S McCullough, L Letzig, PJ Mishra, C Luo, ... Scientific reports 7 (1), 12331, 2017 | 54 | 2017 |
Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells N Bansal, PJ Mishra, M Stein, RS DiPaola, JR Bertino Oncotarget 6 (17), 15321, 2015 | 49 | 2015 |